ARENA PHARMACEUTICALS INC's ticker is and the CUSIP is 040047902. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $155,000 | +0.6% | 90,600 | +15.7% | 0.00% | – |
| Q1 2016 | $154,000 | +54.0% | 78,300 | +48.3% | 0.00% | – |
| Q4 2015 | $100,000 | +42.9% | 52,800 | +43.1% | 0.00% | – |
| Q3 2015 | $70,000 | -80.0% | 36,900 | -51.1% | 0.00% | – |
| Q2 2015 | $350,000 | +43.4% | 75,500 | +35.1% | 0.00% | – |
| Q1 2015 | $244,000 | -68.1% | 55,900 | -74.6% | 0.00% | -100.0% |
| Q4 2014 | $764,000 | +189.4% | 220,100 | +249.9% | 0.00% | – |
| Q3 2014 | $264,000 | -48.4% | 62,900 | -27.9% | 0.00% | -100.0% |
| Q2 2014 | $512,000 | -46.6% | 87,300 | -42.7% | 0.00% | 0.0% |
| Q1 2014 | $959,000 | -36.2% | 152,300 | -40.7% | 0.00% | -50.0% |
| Q4 2013 | $1,503,000 | +16.4% | 256,900 | +4.9% | 0.00% | 0.0% |
| Q3 2013 | $1,291,000 | -60.3% | 245,000 | -42.0% | 0.00% | -66.7% |
| Q2 2013 | $3,252,000 | – | 422,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 2,306 | $966,000 | 0.04% |
| Citadel Advisors | 62,900 | $264,000 | 0.00% |